CLL-OUTCOME will be carried out as a collaborative effort including clinical, molecular, computational, and health economic research groups in CLL in Europe. It will benefit from the transnational consortium, including established access to patient samples and ongoing clinical trials from several European countries. The consortium is interdisciplinary, reflecting the complex process of developing and implementing new prognostic models for personalised medicine.

2025

2028